Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan.

MLA

Wang, Bo-Ren, et al. “Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan.” Life (2075-1729), vol. 14, no. 7, July 2024, p. 801. EBSCOhost, https://doi.org/10.3390/life14070801.

APA

Wang, B.-R., Ma, H.-H., Chang, C.-H., Liao, C.-H., Chang, W.-S., Mong, M.-C., Yang, Y.-C., Gu, J., Bau, D.-T., & Tsai, C.-W. (2024). Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan. Life (2075-1729), 14(7), 801. https://doi.org/10.3390/life14070801

Chicago

Wang, Bo-Ren, Hung-Huan Ma, Chao-Hsiang Chang, Cheng-Hsi Liao, Wen-Shin Chang, Mei-Chin Mong, Ya-Chen Yang, Jian Gu, Da-Tian Bau, and Chia-Wen Tsai. 2024. “Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan.” Life (2075-1729) 14 (7): 801. doi:10.3390/life14070801.